REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 204 filers reported holding REATA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $166,500 | +241204.3% | 1,633 | +114.9% | 0.01% | +200.0% |
Q1 2023 | $69 | +331.2% | 760 | +75.5% | 0.00% | +100.0% |
Q4 2022 | $16 | -100.0% | 433 | -85.0% | 0.00% | 0.0% |
Q3 2022 | $72,000 | +125.0% | 2,881 | +176.8% | 0.00% | 0.0% |
Q2 2022 | $32,000 | -89.9% | 1,041 | -89.2% | 0.00% | -66.7% |
Q1 2022 | $317,000 | +403.2% | 9,676 | +304.3% | 0.00% | +200.0% |
Q4 2021 | $63,000 | +50.0% | 2,393 | +471.1% | 0.00% | 0.0% |
Q3 2021 | $42,000 | -77.3% | 419 | -68.0% | 0.00% | -80.0% |
Q2 2021 | $185,000 | +230.4% | 1,311 | +133.3% | 0.01% | +400.0% |
Q1 2021 | $56,000 | -17.6% | 562 | +2.4% | 0.00% | -50.0% |
Q4 2020 | $68,000 | -37.6% | 549 | -51.0% | 0.00% | +100.0% |
Q3 2020 | $109,000 | -82.2% | 1,121 | -71.5% | 0.00% | -96.0% |
Q2 2020 | $614,000 | +62.4% | 3,936 | +50.4% | 0.02% | +8.7% |
Q1 2020 | $378,000 | +759.1% | 2,617 | +380.2% | 0.02% | +666.7% |
Q3 2019 | $44,000 | +1366.7% | 545 | +1603.1% | 0.00% | – |
Q2 2019 | $3,000 | -50.0% | 32 | -68.6% | 0.00% | – |
Q4 2018 | $6,000 | -94.7% | 102 | -92.7% | 0.00% | -100.0% |
Q3 2018 | $114,000 | +776.9% | 1,398 | +276.8% | 0.01% | +700.0% |
Q2 2018 | $13,000 | -83.3% | 371 | -86.6% | 0.00% | -90.0% |
Q4 2017 | $78,000 | +90.2% | 2,771 | +108.2% | 0.01% | +233.3% |
Q3 2017 | $41,000 | +925.0% | 1,331 | +758.7% | 0.00% | – |
Q1 2017 | $4,000 | -66.7% | 155 | -72.4% | 0.00% | -100.0% |
Q4 2016 | $12,000 | +300.0% | 562 | +462.0% | 0.00% | – |
Q3 2016 | $3,000 | -62.5% | 100 | -76.9% | 0.00% | -100.0% |
Q2 2016 | $8,000 | – | 432 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |